Table 2 Response to IMRT by category of symptoms
From: Clinical outcomes of graves’ ophthalmopathy treated with intensity modulated radiation therapy
Category | No. (%) | CR No. | Percentage | CR & PR No. | Percentage |
|---|---|---|---|---|---|
NOSPECS classification system | |||||
Soft tissue involvement (S) | 85 (73.3) | 14 | 16.5% | 52 | 61.2% |
Proptosis (P) | 78 (67.2) | 8 | 10.3% | 32 | 41.0% |
EOM dysfunction (E) | 62 (53.4) | 20 | 32.3% | 34 | 54.8% |
Corneal involvement (C) | 7 (6.0) | 2 | 28.6% | 3 | 42.9% |
Sight loss (S) | 23 (19.8) | 4 | 17.4% | 10 | 43.5% |
Three additional symptom categories | |||||
Orbital pain | 45 (38.8) | 32 | 71.1% | 37 | 82.2% |
Tearing | 50 (43.1) | 17 | 34.0% | 38 | 76.0% |
Diplopia | 39 (33.6) | 9 | 23.1% | 22 | 56.4% |